A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/15/2011	CA2480889C External preparation for wounds
11/15/2011	CA2464522C Soft gel delivery system for treating poultry
11/15/2011	CA2422031C Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
11/15/2011	CA2372929C Medicament for topical application
11/15/2011	CA2318392C Mammalian appeasing pheromones to decrease stress, anxiety and aggressiveness
11/10/2011	WO2011140550A2 Immunogen adherence and method of making and using same
11/10/2011	WO2011140524A1 Compositions and methods for enhancing physiological performance and recovery time
11/10/2011	WO2011140519A2 In vivo gelling pharmaceutical pre-formulation
11/10/2011	WO2011140446A2 Pharmaceutical formulations
11/10/2011	WO2011140376A1 Controlled drug release from dendrimers
11/10/2011	WO2011140310A2 Povidone-iodine topical composition
11/10/2011	WO2011140274A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
11/10/2011	WO2011140236A2 Triamcinolone acetonide formulations for treating dermatitis and psoriasis
11/10/2011	WO2011140203A2 Stabilized ophthalmic galactomannan formulations
11/10/2011	WO2011140136A2 Drug delivery coating and devices
11/10/2011	WO2011140128A2 Nail discoloration and fungus treatment
11/10/2011	WO2011140126A2 Nail discoloration and fungus treatment
11/10/2011	WO2011140106A1 Micropellet compositions comprising pancreatin containing digestive enzyme mixtures
11/10/2011	WO2011140024A2 Nanoparticles produced from recombinant polymers and methods of making and using the same
11/10/2011	WO2011139927A1 Methods devices and systems of preparing targeted microbubble shells
11/10/2011	WO2011139899A2 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
11/10/2011	WO2011139838A2 Intranasal formulations
11/10/2011	WO2011139796A2 Self-folding sub-centimeter structures
11/10/2011	WO2011139684A2 Nicotine-containing pharmaceutical compositions
11/10/2011	WO2011139595A2 Elongated biodegradable depot for sustained drug release to treat chronic pelvic pain
11/10/2011	WO2011139594A2 Artificial bursa for intra-articular drug delivery
11/10/2011	WO2011139525A1 Stereoisomer of naloxone and potential therapeutic action of opioid drugs to reverse clinical tolerance to these agents
11/10/2011	WO2011139486A2 Layered drug delivery device
11/10/2011	WO2011139479A2 High shear application in drug delivery
11/10/2011	WO2011139478A2 High shear application in medical therapy
11/10/2011	WO2011139420A2 Propynylaminoindan transdermal compositions
11/10/2011	WO2011139414A2 Dexlansoprazole polymorphic forms
11/10/2011	WO2011139354A1 Preparation for weight loss management
11/10/2011	WO2011139348A2 Uses of phospholipid conjugates of synthetic tlr7 agonists
11/10/2011	WO2011139271A1 Immediate release formulations and dosage forms of gamma-hydroxybutyrate
11/10/2011	WO2011139256A2 Stable rosuvastatin formulations
11/10/2011	WO2011139255A2 Pharmaceutical compositions comprising cefetamet
11/10/2011	WO2011139254A2 Pharmaceutical formulations compising cefuroxime axetil
11/10/2011	WO2011139253A2 Pharmaceutical compositions comprising ceftibuten
11/10/2011	WO2011139252A2 Efervescent formulations comprising cefdinir
11/10/2011	WO2011139251A1 Pharmaceutical compositions comprising cefditoren pivoxil
11/10/2011	WO2011139250A2 Water dispersible formulation
11/10/2011	WO2011139249A2 Pharmaceutical composition comprising cefdinir
11/10/2011	WO2011139218A1 Nucleic acid delivery vehicle uses thereof
11/10/2011	WO2011139103A2 Method for producing a water-insoluble gel composition and a water-insoluble gel produced thereby
11/10/2011	WO2011139101A2 Method for producing the solid phase of a water-insoluble gel composition and a water-insoluble gel produced thereby
11/10/2011	WO2011139044A2 Controlled-release pharmaceutical composition including tamsulosin or the pharmaceutically acceptable salts thereof, and oral preparation including same
11/10/2011	WO2011138973A1 Vitamin-containing nutrition infusion for administration through peripheral vein
11/10/2011	WO2011138802A1 Injection solution
11/10/2011	WO2011138801A1 Novel ophthalmic compositions
11/10/2011	WO2011138797A2 Delayed release oral disintegrating pharmaceutical compositions of lansoprazole
11/10/2011	WO2011138772A1 A pharmaceutical composition comprising aspirin and bisoprolol
11/10/2011	WO2011138484A1 Aqueous pharmaceutical system for the administration of drugs to the nails
11/10/2011	WO2011138380A1 Pharmaceutical formulations comprising pioglitazone and linagliptin
11/10/2011	WO2011138364A1 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
11/10/2011	WO2011138262A1 Topical pharmaceutical composition comprising heparin
11/10/2011	WO2011138228A1 Aqueous composition for ophthalmic or dermal use
11/10/2011	WO2011138197A2 Novel low concentration meloxicam tablets
11/10/2011	WO2011138155A1 Chitosan composition
11/10/2011	WO2011138050A1 Method for vaccination
11/10/2011	WO2011138049A1 Mucosal film containing two sugar substitutes
11/10/2011	WO2011138037A2 Solid tapentadol in non-crystalline form
11/10/2011	WO2011137894A1 Melting tablet comprising a triptane or atypical neuroleptic
11/10/2011	WO2011137877A2 A pharmaceutical composition containing solifenacin and a method of its manufacture
11/10/2011	WO2011137601A1 Compound pharmaceutical formulation of levoamlodipine
11/10/2011	WO2011137514A1 Imageable activatable agent for radiation therapy and method and system for radiation therapy
11/10/2011	WO2011137491A1 Novel drug delivery system
11/10/2011	WO2011112996A3 Injectable drug delivery system
11/10/2011	WO2011112893A9 Compositions for ameliorating cell proliferative disorders and methods of making and using them
11/10/2011	WO2011110854A3 The use of amisulpride as an anti-emetic
11/10/2011	WO2011110166A3 Solid pharmaceutical composition, comprising donepezil hydrochloride of the crystalline polymorphous form i
11/10/2011	WO2011107812A3 Stabilized pharmaceutical composition
11/10/2011	WO2011107436A3 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
11/10/2011	WO2011104652A3 Veterinary compositions
11/10/2011	WO2011103150A3 Lyophilized preparations of bendamustine
11/10/2011	WO2011093612A3 Oral complex composition comprising pseudoephedrine and levocetirizine
11/10/2011	WO2011090305A3 Liquid formulations for long-acting g-csf conjugate
11/10/2011	WO2011086574A3 Formulations of nano-carriers and methods of preparing the same
11/10/2011	WO2011085298A3 Compositions comprising pigment particles entrapped in collapsed polymeric microspheres, and methods of making the same
11/10/2011	WO2011084967A3 Methods and compositions for providing protective immunity in the elderly
11/10/2011	WO2011082384A3 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
11/10/2011	WO2011082283A9 Management of myoclonus with oral liposomal reduced glutathione
11/10/2011	WO2011081430A3 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
11/10/2011	WO2011080502A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	WO2011080501A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	WO2011080500A3 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/10/2011	WO2011066390A3 Nanoscale adjuvants and related pharmaceutical compositions and methods
11/10/2011	WO2011051916A3 Stabilized protein formulations and use thereof
11/10/2011	WO2011047837A3 Melt-granulated cinacalcet
11/10/2011	WO2011047047A3 Composites containing polypeptides attached to polysaccharides and molecules
11/10/2011	WO2011034514A3 Stable micronized granules having high solubility
11/10/2011	WO2010136739A3 Controlled-release floating pharmaceutical compositions
11/10/2011	WO2010134025A3 Oral compositions of celecoxib
11/10/2011	WO2010119369A3 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it
11/10/2011	WO2010109330A3 Cholesterol level lowering liposomes
11/10/2011	WO2010107487A3 Lipid-drug conjugates for drug delivery
11/10/2011	US20110277046 Hydrolases, nucleic acids encoding them and methods for making and using them
11/10/2011	US20110275904 Ambulatory medical apparatus with hand held communication device
11/10/2011	US20110275706 Pharmaceutical Compositions Containing Lipase Inhibitors
11/10/2011	US20110275705 Stable injectable oil-in-water docetaxel nanoemulsion

1 ... 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 ... 2991